News headlines about Danaher Corporation (NYSE:DHR) have trended somewhat positive on Saturday, according to Accern. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Danaher Corporation earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave media stories about the conglomerate an impact score of 46.8734977146183 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

These are some of the news articles that may have impacted Accern’s scoring:

Several research firms have recently weighed in on DHR. Janney Montgomery Scott downgraded Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. BidaskClub raised Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, June 21st. Deutsche Bank AG reissued a “buy” rating and set a $97.00 target price on shares of Danaher Corporation in a research report on Wednesday, June 21st. Zacks Investment Research downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Monday, June 19th. Finally, Credit Suisse Group reissued a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $91.76.

Danaher Corporation (NYSE DHR) traded down 0.05% during trading on Friday, hitting $80.87. The stock had a trading volume of 2,861,306 shares. Danaher Corporation has a one year low of $75.71 and a one year high of $88.01. The company has a market cap of $56.18 billion, a P/E ratio of 25.81 and a beta of 1.03. The firm has a 50 day moving average of $82.32 and a 200-day moving average of $84.22.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.90 EPS. Equities analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider William King sold 7,458 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock valued at $3,206,426 over the last three months. Company insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/19/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-danaher-corporation-dhr-share-price.html.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Insider Buying and Selling by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.